BusinessExosome Diagnostics Expands National Sales Team after Blockbuster Quarter with its Flagship Diagnostic, ExoDx Prostate®(IntelliScore) (EPI) TestBy Nasdaq OMXMay 8, 2018, 10:30 AM UTC
BusinessRecent Publication Highlights Proof-of-Concept Data Supporting the Diagnostic Potential of Phosphatidylserine-Positive Exosomes in Ovarian CancerBy Nasdaq OMXFeb 9, 2017, 1:05 PM UTC
